# Myseum.AI, Inc.: overview MYSE · Nasdaq · CIK 1648960 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/myse.md) · [Financials](/companies/myse/financials.md) · [Filings](/companies/myse/filings.md) · [Insiders](/companies/myse/insiders.md) Latest reported revenue: [$37](/filings/0001213900-26-090015.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:Revenues, accession 0001213900-26-090015). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [0.1](/filings/0001213900-25-110045.md) | [0.1 d](/filings/0001213900-26-036485.md) | [0.1](/filings/0001213900-26-057778.md) | [0.1](/filings/0001213900-26-090015.md) | [0.3](/filings/0001213900-25-110045.md) | [0.1 d](/filings/0001213900-26-036485.md) | [0.1](/filings/0001213900-26-057778.md) | [0.0](/filings/0001213900-26-090015.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(1997071.0%)](/filings/0001213900-25-110045.md) | [1034281.5% d](/filings/0001213900-26-036485.md) | [(1727663.9%)](/filings/0001213900-26-057778.md) | [(1530975.6%)](/filings/0001213900-26-090015.md) | [(390427.1%)](/filings/0001213900-25-110045.md) | [(1872431.1%) d](/filings/0001213900-26-036485.md) | [(2308863.0%)](/filings/0001213900-26-057778.md) | [(5817056.8%)](/filings/0001213900-26-090015.md) | | Net margin | % | [(2051291.9%)](/filings/0001213900-25-110045.md) | [(919891.3%) d](/filings/0001213900-26-036485.md) | [(1774934.9%)](/filings/0001213900-26-057778.md) | [(1560092.3%)](/filings/0001213900-26-090015.md) | [(366304.0%)](/filings/0001213900-25-110045.md) | [2105365.6% d](/filings/0001213900-26-036485.md) | [(3920013.7%)](/filings/0001213900-26-057778.md) | [(8244227.0%)](/filings/0001213900-26-090015.md) | | Diluted EPS | $ per share | [(0.42)](/filings/0001213900-25-110045.md) | not reported | [(0.36)](/filings/0001213900-26-057778.md) | [(0.29)](/filings/0001213900-26-090015.md) | [(0.28)](/filings/0001213900-25-110045.md) | not reported | [(0.67)](/filings/0001213900-26-057778.md) | [(0.61)](/filings/0001213900-26-090015.md) | | Free cash flow | $k | not reported | not reported | not reported | not reported | [(1,033) d](/filings/0001213900-25-110045.md) | [(752) d](/filings/0001213900-26-036485.md) | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [4.4](/filings/0001213900-23-025416.md) | [46.2](/filings/0001213900-24-027991.md) | [0.7](/filings/0001013762-25-004290.md) | [0.4](/filings/0001213900-26-036485.md) | [0.6](/filings/0001213900-26-036485.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(243836.9%)](/filings/0001213900-23-025416.md) | [(26456.8%)](/filings/0001213900-24-027991.md) | [(1307147.5%)](/filings/0001013762-25-004290.md) | [(737882.3%)](/filings/0001213900-26-036485.md) | [(998192.4%)](/filings/0001213900-26-036485.md) | | Net margin | % | [(243622.8%)](/filings/0001213900-23-025416.md) | [(26266.0%)](/filings/0001213900-24-027991.md) | [(1250739.6%)](/filings/0001013762-25-004290.md) | [(972284.4%)](/filings/0001213900-26-036485.md) | [(474049.5%)](/filings/0001213900-26-036485.md) | | Diluted EPS | $ per share | [(0.71)](/filings/0001213900-23-025416.md) | [(6.04)](/filings/0001213900-24-027991.md) | [(4.14)](/filings/0001013762-25-004290.md) | [(1.43)](/filings/0001213900-26-036485.md) | [(0.62)](/filings/0001213900-26-036485.md) | | Free cash flow | $k | [(8,511)](/filings/0001213900-23-025416.md) | [(7,303)](/filings/0001213900-24-027991.md) | [(6,579)](/filings/0001013762-25-004290.md) | not reported | [(4,272)](/filings/0001213900-26-036485.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/myse/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $258.9k | 102,736 | | New +102,736 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $90.1k | 35,757 | | Reduced −85,916 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $82.9k | 32,906 | | Unchanged | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $37.8k | 14,994 | | Unchanged | | [OSAIC HOLDINGS, INC.](/funds/1677044.md) | 2026-06-30 | $9.6k | 3,807 | | Added +2 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $9.3k | 3,708 | | Added +3,695 | | [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $3.0k | 1,200 | | Reduced −321 | | [ASSETMARK, INC](/funds/1344551.md) | 2026-06-30 | $1.0k | 400 | | Unchanged | | [IFP Advisors, Inc](/funds/1641866.md) | 2026-06-30 | $504 | 200 | | Unchanged | | [SBI Securities Co., Ltd.](/funds/1851815.md) | 2026-06-30 | $179 | 71 | | Reduced −42 | ## Recent filings [All 242 filings](/companies/myse/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-23 | 16:30 ET | [8-K](/filings/0001213900-26-102642.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-102642 | | 2026-09-21 | 16:16 ET | [8-K](/filings/0001213900-26-101814.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-101814 | | 2026-09-17 | 16:30 ET | [8-K](/filings/0001213900-26-100979.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-100979 | | 2026-08-14 | 16:03 ET | [10-Q](/filings/0001213900-26-090015.md) | Quarterly report, period 2026-06-30 | 0001213900-26-090015 | | 2026-08-12 | 16:30 ET | [8-K](/filings/0001213900-26-088393.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-088393 | | 2026-08-06 | 16:16 ET | [8-K](/filings/0001213900-26-086152.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-086152 | | 2026-07-22 | 16:15 ET | [8-K](/filings/0001213900-26-080405.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-080405 | | 2026-06-23 | 16:15 ET | [DEF 14A](/filings/0001213900-26-071100.md) | Proxy statement, period 2026-08-06 | 0001213900-26-071100 | | 2026-06-18 | 21:24 ET | [8-K](/filings/0001213900-26-069795.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-069795 | | 2026-06-11 | 19:53 ET | [8-K](/filings/0001213900-26-067472.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-067472 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001213900-26-036485.md), filed Mar 30, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/728d9107-243e-4322-b5ed-4f2b9df38fbd) ## About the filer - CIK: 1648960 - Tickers: MYSE - Exchange: Nasdaq - SIC code: 4822 Telegraph & Other Message Communications - State of incorporation: NV - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.